EZ HUBER 22G X 25MM WITH Y-SITE
Report
- Report Number
- 3006260740-2019-00271
- Event Type
- Malfunction
- Date Received
- February 14, 2019
- Report Date
- February 14, 2019
- Manufacturer
- BARD ACCESS SYSTEMS
- Product Code
- FPA
- UDI-DI
- 00801741089275
- PMA / PMN Number
- K071846
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE FOLLOWING WERE REVIEWED AS PART OF THIS INVESTIGATION: PATIENT SEVERITY, TREND ANALYSIS, APPLICABLE PREVIOUS INVESTIGATION(S), SAMPLE (IF AVAILABLE), APPLICABLE FMEA DOCUMENTS, LABELING, AND APPLICABLE MANUFACTURE RECORDS. BASED ON A REVIEW OF THIS INFORMATION, THE FOLLOWING WAS CONCLUDED: THE COMPLAINT OF A LEAKING INFUSION SET WAS INCONCLUSIVE BECAUSE THE IMPLICATED DEVICE WAS NOT RETURNED FOR EVALUATION. THE PRODUCT RETURNED FOR EVALUATION WAS ONE 22GA X 1¿ EZ HUBER SAFETY INFUSION SET. THE SAMPLE WAS RECEIVED IN ITS ORIGINAL SEALED PACKAGING. AN ATTEMPT TO INFUSE WATER THROUGH THE SAMPLE USING A 12ML SYRINGE REVEALED THE SAMPLE TO BE PATENT TO INFUSION AND ASPIRATION WITH NO OBSERVED LEAKS. NO LEAKS WERE OBSERVED DURING SUSTAINED (>15 SECONDS) HYDRAULIC PRESSURIZATION OF THE SAMPLE. MICROSCOPIC INSPECTION OF THE SAMPLE WAS UNREMARKABLE. NO DEFICIENCIES WERE DISCOVERED DURING EVALUATION OF THE RETURNED SAMPLE; HOWEVER, THE SEALED AND UNUSED STATE OF THE RETURNED SAMPLE INDICATED THAT IT WAS NOT THE DEVICE IMPLICATED BY THE COMPLAINANT. CONSEQUENTLY THIS COMPLAINT IS INCONCLUSIVE AT THIS TIME. A LOT HISTORY REVIEW (LHR) OF RECT0218 SHOWED NO OTHER SIMILAR PRODUCT COMPLAINT(S) FROM THIS LOT NUMBER.
IT WAS REPORTED THAT THE EZ HUBER NEEDLE LEAKED AT THE Y-SITE ONTO THE PATIENT DURING THE ADMINISTRATION OF CHEMOTHERAPY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 135251 | EZ HUBER 22G X 25MM WITH Y-SITE | SET, ADMINISTRATION, INTRAVASCULAR | FPA | BARD ACCESS SYSTEMS | N/A | RECT0218 | 00801741089275 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |